| Dr David Allan Norton, MD | |
|
9898 Genesee Ave, La Jolla, CA 92037-1205 | |
| (858) 824-5404 | |
| (858) 964-3128 |
| Full Name | Dr David Allan Norton |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 27 Years |
| Location | 9898 Genesee Ave, La Jolla, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932246915 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Scripps Memorial Hospital La Jolla | La jolla, CA | Hospital |
| Scripps Green Hospital | La jolla, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scripps Health | 9234033853 | 1362 |
| Scripps Health Inpatient Providers Medical Group Inc | 9436314762 | 143 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded grants for five projects under the Qualifying Therapeutic Discovery Project (QTDP) program.
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Most migraine and post-traumatic headache sufferers find their headaches get worse in light, leading them to quit their most fundamental daily tasks and seek the comfort of darkness.
Rising global temperatures over the past two decades may be responsible for a shortened season of a serious respiratory illness in the United Kingdom, according to an article in the March 1 issue of Clinical Infectious Diseases.
› Verified 5 days ago
| Entity Name | Scripps Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636108 PECOS PAC ID: 9234033853 Enrollment ID: O20031124000822 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded grants for five projects under the Qualifying Therapeutic Discovery Project (QTDP) program.
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Most migraine and post-traumatic headache sufferers find their headaches get worse in light, leading them to quit their most fundamental daily tasks and seek the comfort of darkness.
Rising global temperatures over the past two decades may be responsible for a shortened season of a serious respiratory illness in the United Kingdom, according to an article in the March 1 issue of Clinical Infectious Diseases.
› Verified 5 days ago
| Entity Name | Scripps Health Inpatient Providers Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699043000 PECOS PAC ID: 9436314762 Enrollment ID: O20120711000317 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded grants for five projects under the Qualifying Therapeutic Discovery Project (QTDP) program.
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Most migraine and post-traumatic headache sufferers find their headaches get worse in light, leading them to quit their most fundamental daily tasks and seek the comfort of darkness.
Rising global temperatures over the past two decades may be responsible for a shortened season of a serious respiratory illness in the United Kingdom, according to an article in the March 1 issue of Clinical Infectious Diseases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Allan Norton, MD 10790 Rancho Bernardo Rd, San Diego, CA 92127-5705 Ph: (858) 824-5404 | Dr David Allan Norton, MD 9898 Genesee Ave, La Jolla, CA 92037-1205 Ph: (858) 824-5404 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded grants for five projects under the Qualifying Therapeutic Discovery Project (QTDP) program.
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Most migraine and post-traumatic headache sufferers find their headaches get worse in light, leading them to quit their most fundamental daily tasks and seek the comfort of darkness.
Rising global temperatures over the past two decades may be responsible for a shortened season of a serious respiratory illness in the United Kingdom, according to an article in the March 1 issue of Clinical Infectious Diseases.
› Verified 5 days ago
Dr. John Sturdivant Andrews, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1223 Via Barranca, La Jolla, CA 92037 Phone: 858-775-1976 | |
Dr. Mark C Adrian, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, Suite 355, La Jolla, CA 92037 Phone: 858-202-0011 | |
Dr. Erminia M. Guarneri, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-3330 Fax: 858-784-5933 | |
Dr. Eric Hong, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9834 Genesee Ave, Suite 300, La Jolla, CA 92037 Phone: 858-824-2900 Fax: 858-824-2910 | |
Katrina Deleon, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-6158 | |
Abhishek Gadre, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-7118 | |
Kamran Hussain Imam, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-6158 |